The National Cancer Network (NCCN) released the first edition of its 2015 non-small cell lung cancer treatment guidelines Small Cell Lung Cancer Treatment Guidelines on October 21, 2014. Medical Pulse has compiled the following excerpts of the treatment recommendations for treatment-sensitive EGFR mutation-positive NSCLC, ALK-positive NSCLC and lung adenocarcinoma, large cell lung cancer, and non-specific NSCLC (NSCLC-NOS) for the benefit of readers. Download the full text of the guidelines by Zhiyong Ma, Department of Internal Medicine, Henan Cancer Hospital “NCCN clinical practice guideline: non-small cell lung cancer (2015.V1) Sequential treatment of treatment-sensitive EGFR mutation-positive NSCLC after disease progression in first-line therapy Sequential treatment of ALK-positive NSCLC after disease progression in first-line therapy　　Adenocarcinoma, large cell, NSCLC-NOS First-line therapy Sequential therapy after disease progression